| Recruitment status | Enrolling by invitation |
| Unique ID issued by UMIN | UMIN000027423 |
| Receipt No. | R000031423 |
| Scientific Title | Qualitative and quantitative changes in skin T cells during treatments of skin disorders |
| Date of disclosure of the study information | 2017/06/01 |
| Last modified on | 2019/05/23 (Ver. 3) |
| Basic information | ||
| Public title | Qualitative and quantitative changes in skin T cells during treatments of skin disorders | |
| Acronym | Skin disorders and skin T cells | |
| Scientific Title | Qualitative and quantitative changes in skin T cells during treatments of skin disorders | |
| Scientific Title:Acronym | Skin disorders and skin T cells | |
| Region |
|
|
| Condition | ||
| Condition | inflammatory skin disorders, allergic skin disorders, collagen disease | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To reveal the qualitative and quantitative changes in skin T cells and blood T cells during treatments of skin disorders and to find the specific changes of skin T cells according to treatment modalities. |
| Basic objectives2 | Others |
| Basic objectives -Others | To reveal the changes of skin T cells before and after treatments |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Percentages of CCR7+CD62L+ central memory T cells, CCR7+CD62L- migratory memory T cells and CD69+CD103+ resident memory T cells in total T cells in lesional skin, non-lesional skin and blood before and after treatments. |
| Key secondary outcomes | |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Uncontrolled |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 1 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | To collect skin biopsy specimens and blood samples after skin lesion is cleared by any kinds of treatments | |
| Interventions/Control_2 | ||
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | The skin disorder patients whose skin lesions disappeared after any kinds of treatments and who underwent skin biopsies for the sake of diagnosis before treatments. | |||
| Key exclusion criteria | None | |||
| Target sample size | 45 | |||
| Research contact person | |||||||
| Last name of lead principal investigator |
|
||||||
| Organization | University of Tsukuba | ||||||
| Division name | Division of Medicine, Department of Dermatology | ||||||
| Zip code | 305-8575 | ||||||
| Address | 1-1-1, Tennodai, Tsukuba-shi, Ibaraki, Japan | ||||||
| TEL | 029-853-3128 | ||||||
| rwatanabe@md.tsukuba.ac.jp | |||||||
| Public contact | |||||||
| 1st name of contact person |
|
||||||
| Organization | University of Tsukuba | ||||||
| Division name | Division of Medicine, Department of Dermatology | ||||||
| Zip code | 305-8575 | ||||||
| Address | 1-1-1, Tennodai, Tsukuba-shi, Ibaraki, Japan | ||||||
| TEL | 029-853-3128 | ||||||
| Homepage URL | |||||||
| rwatanabe@md.tsukuba.ac.jp | |||||||
| Sponsor | |
| Institute | University of Tsukuba |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Grants-in-Aid for Scientific Research |
| Organization | |
| Division | |
| Category of Funding Organization | Japanese Governmental office |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Faculty of Medicine, University of Tsukuba |
| Address | 1-1-1 Tennodai, Tsukuba, Ibaraki |
| Tel | +81298533128 |
| rwatanabe@md.tsukuba.ac.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Enrolling by invitation | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000031423 |